Accrelist (SGX:QZG) signed a non-binding term sheet to acquire a 51% stake in a Chinese medical aesthetics business for 10.2 million yuan, according to a Tuesday filing with the Singapore Exchange.
Shares of the aesthetics company fell nearly 2% in Wednesday trading.
The deal is structured around the target meeting net profits of at least 2 million yuan annually over three financial years.
The move is part of the company's strategy to capture China's growing medical aesthetics market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments